For those suffering from chronic obstructive pulmonary disease (COPD) and other lung diseases like interstitial lung disease, and pulmonary fibrosis, finding a form of treatment that isn’t coupled with a range of negative side-effects can be difficult. When traditional options for treatment fail to meet the expectations of those with the disease, they turn to the Lung Institute and cellular therapy to not only address their symptoms but the progression of the disease itself. With your health in mind, here are a few patient treatment success stories & news about the changes they’ve seen in their quality of life after cellular therapy.
As the scientific community continues to put their best minds to the task of solving the problems and complications of the human body, the Lung Institute will continue to help people with chronic lung disease bring their lives back within reach.
When it comes to cellular therapy, people have a number of questions. Here is a list of the frequently asked questions (FAQs) we’ve received:
While our treatments have shown to improve many patients’ quality of life at all stages of lung disease, our patients’ results have shown to be most effective the earlier treatment is begun. More than 84 percent report a better quality of life within three months of treatment. While our treatment is not a cure, it has shown to significantly slow down and potentially even halt the progression of COPD and ILD.
Because we use your cells, the risk of rejection or side effects is very minimal and nearly nonexistent.
Our cellular therapy does not need to be FDA approved because it is not a drug. But, we do operate in compliance with the FDA 1271 regulation exemption1 which allows for same day medical procedures involving cells and HCT/Ps (Human Cells, Tissues, & Cellular and Tissue Based Products) to be considered the practice of medicine.
Treatment cost varies depending on treatment type. We understand that each patient is unique and has individual needs. Because of that, we make sure to go over the patient’s history and our treatment options in detail with each patient.
Unfortunately, at this time, insurance companies don’t cover treatment. We’re hopeful treatment will be covered by insurance companies in the near future. It will take some time before insurance companies see a financial benefit in their favor and decide to cover it. In the meantime, you can learn more about cellular therapy options and have your questions answered by one of our patient coordinators.
Our patient coordinators will gladly work with you to set up a reasonable payment plan.
The Lung Institute is passionate about improving the lives of people living with chronic lung diseases. At the Lung Institute, we offer cellular therapy for people with chronic lung diseases. We understand that every condition is different and that each of our patients has a unique story. Our team of dedicated medical professionals is ready to answer your questions and provide top quality care. Our goal is to help people enjoy their favorite activities, spend more time with their families and grandchildren and breathe easier.
Regenerative medicine is an emerging field of medicine that aims to address the root cause of degenerative diseases that have been considered very difficult to successfully treat. With the medical advancements of regenerative medicine, specialized physicians can use your cells to help promote healing of organs.
Cells are found in multicellular organisms and are the building blocks of life. In fact, cells have the ability to self-renew and replicate. Adult cells are called undifferentiated cells, meaning they can transform their function to that of other tissues in the body. Autologous cells or adult cells are derived from the patient’s own body.
At the Lung Institute, we specialize in cellular therapy for people living with certain chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), emphysema,pulmonary fibrosis, interstitial lung disease and others. During our stem cell procedures, trained medical specialists harvest cells from a sample of a patient’s blood or bone marrow tissue, separate and process them from the other cells in the sample in our on-site lab and then return the cells to the patient intravenously. Once returned to the patient, the cells may begin to promote healing from within the lungs.
At the Lung Institute, many of our patients are surprised at the ease of our cellular therapys. All of our treatments are minimally invasive and outpatient. While everyone’s pain threshold varies, we work hard to make our treatments as pain-free as possible.
No, the Lung Institute does not use fetal or embryonic cells. At the Lung Institute, we only use adult autologous cells derived from the patient’s own body.
To determine if you’re a candidate, we’re happy to offer a complimentary review of your medical records. Our dedicated medical staff are ready to answer your questions and discuss the treatment options available. Feel free to contact us at 888-745-6697 to speak one-on-one with our medical staff today.
The risk of rejection is very minimal and nearly nonexistent.
Innovations in the field of regenerative medicine are newer and emerging in medical technology. Currently, the highly specialized methods are not taught in traditional medical schools or residency programs. At the Lung Institute, our advanced procedures are specialized, and our physicians receive additional training for the best quality of care for our patients.
COPD affects people differently and at varying rates of progression. Sometimes, doctors may try to estimate life expectancy but there isn’t a way for anyone to know an exact life expectancy. For some people, COPD progresses rapidly, and for others, COPD progresses slowly over time. Currently, there isn’t a cure for COPD, but there are treatment options available to help people manage symptoms.
Pulmonary fibrosis is a progressive form of lung disease, meaning it will worsen over time. Like COPD, pulmonary fibrosis affects people differently and at varying rates of progression. Doctors may try to estimate life expectancy with pulmonary fibrosis but there is not a way for anyone to know an exact life expectancy. At this point, there is not a cure for pulmonary fibrosis. However, treatment options are available to help people living with pulmonary fibrosis manage their symptoms.
Like COPD and pulmonary fibrosis, emphysema affects everyone differently and at different rates of progression. While doctors may try to approximate life expectancy for someone with emphysema, there is no way for anyone to know an exact life expectancy. While there isn’t a cure for emphysema, there are various treatment options available to help manage symptoms.
The BODE Index is a way for doctors to place certain lung diseases, such as COPD and emphysema, into stages. The BODE Index accounts for how the disease affects your life.
BODE stands for body mass, obstruction of airflow, dyspnea (difficulty breathing) and exercise capacity.
Obstruction of Airflow
Dyspnea (difficulty breathing)
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) developed the GOLD System. The GOLD System uses the forced expiratory volume in one second (FEV1) measurement from your pulmonary function test to categorize certain lung diseases, such as COPD and emphysema, into stages. There are four total stages in the GOLD System.
Stage 1: Very mild COPD with a FEV1 about 80 percent or more of normal.
Stage 2: Moderate COPD with a FEV1 between 50 and 80 percent of normal.
Stage 3: Severe emphysema with FEV1 between 30 and 50 percent of normal.
Stage 4: Very severe COPD with lower FEV1 than Stage 3, or those with Stage 3 FEV1 and low blood oxygen levels.
For more patient treatment success stories & news, check out other patients’ testimonials. You can take the first step to easier breathing by contacting us at 888-745-6697. We’re happy to answer your questions and are ready to help you today. If you or a loved one suffers from COPD, or another lung disease, the Lung Institute may be able to help with a variety of cellular therapy options.
All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.